Evidence map›Paper›PMID 32350710›Full record

ArticleEndocrine2020

Wolfram syndrome: clinical and genetic profiling of a cohort from a tertiary care centre with characterization of the primary gonadal failure.

Liza Das, Ashutosh Rai, Ravimohan Mavuduru, Kim Vaiphei, Akhilesh Sharma, Vishali Gupta, Sanjay Kumar Bhadada, Sailesh Lodha, Naresh Panda, Anil Bhansali and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Liza Das *Department of Endocrinology, PGIMER, Chandigarh, India.ORCID http://orcid.org/0000-0002-9701-9554
Ashutosh Rai *Department of Translational and Regenerative Medicine, PGIMER, Chandigarh, India.
Ravimohan MavuduruDepartment of Urology, PGIMER, Chandigarh, India.
Kim VaipheiDepartment of Histopathology, PGIMER, Chandigarh, India.
Akhilesh SharmaDepartment of Psychiatry, PGIMER, Chandigarh, India.
Vishali GuptaDepartment of Ophthalmology, PGIMER, Chandigarh, India.
Sanjay Kumar BhadadaDepartment of Endocrinology, PGIMER, Chandigarh, India.
Sailesh LodhaDepartment of Endocrinology, Eternal Heart Care Centre, Jaipur, India.
Naresh PandaDepartment of Otorhinolarygology, PGIMER, Chandigarh, India.
Anil BhansaliDepartment of Endocrinology, PGIMER, Chandigarh, India.
Paramjeet SinghDepartment of Radiology, PGIMER, Chandigarh, India.
Pinaki DuttaDepartment of Endocrinology, PGIMER, Chandigarh, India. pinaki_dutta@hotmail.com.ORCID http://orcid.org/0000-0001-5415-1611
Post Graduate Institute of Medical Education and Research · INEternal Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWolfram syndrome (WFS) is a rare, monogenic neurodegenerative syndrome characterised by insulin requiring non-autoimmune diabetes mellitus (DM) and optic atrophy which are usually the earliest and commonest manifestations. However, there are other features which are under-recognized, adding to morbidity and premature mortality in these patients.

methodsFive patients (three males, two females) with genetically confirmed WFS at a single tertiary care centre were prospectively followed up. Their symptomatology, clinical profile, genetic analysis and radiology were analyzed. Multidisciplinary approach was used for comprehensive clinical care of this cohort. Patients with primary gonadal failure were subjected to biopsy and immunohistochemistry (IHC) for wolframin was performed.

resultsDM was the earliest presenting manifestation at 6.2 ± 1.3 years followed by optic atrophy at 10.4 ± 2.3 years, diabetes insipidus at 12 ± 2.1 years and deafness at 12.8 ± 2.1 years. All patients were autoantibody negative with low C-peptide(<0.6 ng/ml). Hypoglycemic episodes were frequent (upto 60%) but there was no instance of diabetic ketoacidosis. Optic atrophy was present alongwith proliferative diabetic retinopathy and cataract in 40%. Uncommon manifestations included neuropsychiatric features, parasuicide, cystopathy, brainstem atrophy and hypergonadotropic hypogonadism only in adult males (n = 2). Testicular biopsy revealed partly hyalinised seminiferous tubules and prominence of Leydig cells. IHC confirmed the presence of mutated wolframin, which was not significantly different from normal testis specimen on protein quantification.

conclusionsWFS requires a multidisciplinary approach with special emphasis on early diagnosis and management of other endocrine and non-endocrine features so as to improve long-term outcomes. Gonadal functions need periodic assessment, especially in adult males.

Indexed as

HypogonadismOptic AtrophyWolfram SyndromeAdultFemaleGenetic ProfileHumansMaleTertiary Care CentersDIDMOADER stressGonadal failureNeuropsychiatric manifestationsWolfram syndrome

Identifiers

PMID32350710
OpenAlexW3022122243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.